Table 3.
CD4+ Th cells | CD4+ Treg | Tf cells | CD8+ T cells | B cells | |
---|---|---|---|---|---|
CIS |
↑ Th17 (% CD4) 16
↑ (↑↑ in active disease) CD146+ (% CD4) 30 |
No significant differences reported in the cited literature |
↔ Tfh (% CD4) ↓ Tfr (% Treg) 52 |
↓ EM/RA (% PBMC) 56
↔ Tc17 (% CD8) 72 ↔ FoxP3+ (% CD8) 61 |
↓ CD27+ (% B cells) in active disease 80 |
RRMS |
↑ Th17 (% CD4) 17
↔ Th17 (% memory CD4) 6, 18 ↑ CD146+ (% CD4) 30 ↑ GM‐CSF+ (% CD4) 20 |
↓ CD39+ (% Treg) 44
↓ CD39+ (% PBMC) 45 ↓ memory Treg (% CD4) 35 ↓ FoxP3 MFI 39, 40 |
↔ Tfh (% CD4) 52
↑ Tfh (number) 55 ↑ ICOS+ (% Tfh) 7 ↓ Tfh1 (% Tfh) 7 ↓ Tfr (% Treg) 52 ↑ Tfr17 (% Treg) 52 |
↓ EM/RA (% PBMC) 56
↑ Tc17/IFN‐γ+ Tc17 (% CD8) 70 ↑ MAIT (% CD8) 65 ↓ MAIT (% memory CD8 67 and αβT cells 66) ↑ GM‐CSF+ (% CD8) 20 |
↔ B cells (% PBMC) 80
↔ core subsets (% B cells) 80, 81 ↓ IL‐10+ (% B cells) 77 |
RRMS ‐ active |
↑↑ Th17 and Th17.1 (% memory CD4) 6, 18
↑↑ CD146+ (% CD4) 30 |
↓ CD39+ (% Treg) 44
↓ memory Treg (% CD4) 35 ↓ FoxP3 MFI 39, 40 |
↑↑ number of Tfh and ICOS+ Tfh 55 |
↓ EM/RA (% PBMC) 56
↑ Tc17 70, 71/IFN‐γ+ Tc17 (% CD8) 70 ↓ FoxP3+ (% CD8) and FoxP3 MFI 61 ↓↓ MAIT (% αβT cells) 66 |
↓ CD27+ (% B cells) 80, 82
↓ CCR5+ (% total, CD27+ and CD27– B cells) 82 ↓ IL‐10+ (% B cells) 77 |
SPMS and PPMS |
↑ Th17 (% CD4) 7
↑ CD146+ (% CD4) 30 |
No significant differences reported in the cited literature |
↑ Tfh17 (% Tfh) 7
↓ Tfr (% Treg) 52 |
↓ EM/RA (% PBMC) 56 | No significant differences reported in the cited literature |
CIS = clinically isolated syndrome; RRMS = relapsing–remitting multiple sclerosis (MS); SPMS = secondary progressive MS; PPMS = primary progressive MS; Treg = regulatory T cell; Tfh = follicular T helper; EM/RA = effector memory re‐expressing RA T cell; ICOS = inducible T cell co‐stimulator; MAIT = mucosal‐associated invariant T; PBMC = peripheral blood mononuclear cells; GM‐CSF = granulocyte–macrophage colony‐stimulatory factor; FoxP3 = forkhead box protein 3; MFI = mean fluorescence intensity; IFN = interferon; Th = T helper.